Tornier NV  

(Public, NASDAQ:TRNX)   Watch this stock  
Find more results for TRNX
18.35
+0.05 (0.27%)
After Hours: 18.35 0.00 (0.00%)
Apr 23, 5:09PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 17.93 - 18.45
52 week 15.17 - 21.87
Open 18.23
Vol / Avg. 0.00/273,527.00
Mkt cap 890.37M
P/E     -
Div/yield     -
EPS -0.80
Shares 48.52M
Beta 1.26
Inst. own 83%
May 6, 2014
Q1 2014 Tornier NV Earnings Conference Call - 4:30PM EDT - Add to calendar
May 6, 2014
Q1 2014 Tornier NV Earnings Release - 4:00PM EDT - Add to calendar
Feb 25, 2014
Tornier NV at RBC Capital Markets Healthcare Conference
Feb 20, 2014
Q4 2013 Tornier NV Earnings Conference Call
Feb 20, 2014
Q4 2013 Tornier NV Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -12.83% -11.71%
Operating margin -8.80% -8.10%
EBITD margin - 5.22%
Return on average assets -6.15% -5.36%
Return on average equity -8.18% -7.57%
Employees 916 -
CDP Score - -

Address

Olivier van Noortstraat 4
SCHIEDAM, 3124 LA
Netherlands
+31-10-4718888 (Phone)
+31-10-4718888 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Tornier N.V. (Tornier) is a global medical device company focused on surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. Tornier refers to these surgeons as extremity specialists. The Company sells to this extremity specialist customer base a broad line of joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In certain international markets, it also offers joint replacement products for the hip and knee. The Company sells over approximately 100 product lines in approximately 40 countries. The Company�s principal products are organized in four categories: upper extremity joints and trauma, lower extremity joints and trauma, sports medicine and biologics, and large joints and other. The Company�s geographic regions consist of the United States, France and other areas. On October 4, 2012, the Company acquired OrthoHelix.

Officers and directors

David H. Mowry President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Shawn T. McCormick Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Terry M. Rich Senior Vice President - U.S. Commercial Operations
Age: 45
Bio & Compensation  - Reuters
Gordon W. Van Ummersen Senior Vice President of Global Product Delivery
Bio & Compensation  - Reuters
Gregory Morrison Global Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters
Kevin M. Klemz Vice President, Chief Legal Officer, Secretary
Age: 51
Bio & Compensation  - Reuters
Stephan Epinette Vice President - International Commercial Operations
Bio & Compensation  - Reuters
Sean D. Carney Non-Executive Independent Chairman of the Board
Age: 45
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Interim Non-Executive Independent Vice Chairman of the Board
Age: 58
Bio & Compensation  - Reuters
Alain Tornier Non-Executive Director
Age: 66
Bio & Compensation  - Reuters